Srinivasa Kodali
Psychiatry · Livonia, MINPI 1255372058
Payments from drug & device makers
Across 174 payments — averaging $24.49 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Alkermes, Inc.$763
- Otsuka America Pharmaceutical, Inc.$407
- Neurocrine Biosciences, Inc.$386
- AbbVie$352
- Teva Pharmaceuticals USA, Inc.$321
- Lundbeck LLC$291
- plus $2K from 15 others
What the payments were for
- Food & beverage$4,246100%
- Education$160%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Alkermes, Inc. | 14 | $763 |
| Otsuka America Pharmaceutical, Inc. | 14 | $407 |
| Neurocrine Biosciences, Inc. | 12 | $386 |
| AbbVie(2 entities) | 13 | $352 |
| Teva Pharmaceuticals USA, Inc. | 14 | $321 |
| Lundbeck LLC | 15 | $291 |
| Supernus Pharmaceuticals, Inc. | 16 | $273 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 8 | $249 |
| Vanda Pharmaceuticals Inc. | 17 | $211 |
| E.r. Squibb & Sons, L.L.C. | 3 | $158 |
| Sunovion Pharmaceuticals Inc. | 17 | $147 |
| Axsome Therapeutics, Inc. | 1 | $125 |
| Acadia Pharmaceuticals Inc | 1 | $122 |
| Takeda Pharmaceuticals U.S.A., Inc. | 8 | $119 |
| Johnson & Johnson | 4 | $81 |
| Validus Pharmaceuticals LLC | 5 | $76 |
| Ironshore Pharmaceuticals Inc. | 5 | $74 |
| Tris Pharma Inc | 4 | $59 |
| Indivior Inc. | 1 | $22 |
| Vertical Pharmaceuticals, LLC | 1 | $14 |
| Neos Therapeutics, LP | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,262 in reported general payments places this provider in the 90th percentile of 1,166 psychiatry providers in Michigan.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl | 33 | $8,082 |
| Paliperidone ErPaliperidone | 33 | $5,634 |
| Divalproex Sodium ErDivalproex Sodium | 101 | $2,383 |
| Sertraline Hcl | 231 | $1,970 |
| Venlafaxine Hcl ErVenlafaxine Hcl | 49 | $1,396 |
| Quetiapine Fumarate | 111 | $1,240 |
| Trazodone Hcl | 134 | $1,035 |
| Escitalopram Oxalate | 110 | $998 |
| Lurasidone Hcl | 12 | $951 |
| Aripiprazole | 43 | $818 |
| Olanzapine | 24 | $749 |
| Bupropion XlBupropion Hcl | 54 | $735 |
| Lorazepam | 117 | $716 |
| Dextroamphetamine-Amphet ErDextroamphetamine/Amphetamine | 21 | $694 |
| Duloxetine Hcl | 41 | $591 |
Paid to pharmacies, not to this prescriber.
Other psychiatry in Livonia
- Samuel WedesLivonia$158K
- Patrick GreshamLivonia$14K
- Chalakudy RamakrishnaLivonia$13K
- Andreas SidiropoulasDetroit$2.8M
- Joel YoungRochester Hills$1.9M
- Welton WashingtonYpsilanti$1.4M
- Rajaprabhakaran RajarethinamAnn Arbor$1.2M
- Eric AchtyesGrand Rapids$705K
- Manzar RajputMonroe$612K
- William GuySouthfield$562K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.